We then investigated the effects of combination treatment with MYCT1-shRNA and the GSK3β phosphorylation agonist LiCl on TBX21-mediated inhibition of CRC metastasis in a xenograft mouse model in vivo. Here, GSK3B is linked to colorectal carcinoma.